Gland Pharma Ltd quotes at Rs 3388.05, up 1.35% on the day at 12:54 PM IST on the NSE. The stock is up 35.44% over the past year, compared to a 22.25% jump in NIFTY and an 11.08% jump in the Nifty Pharma Index.
Gland Pharma Ltd is up for a third consecutive session today. The stock is trading at Rs 3388.05, up 1.35% on the day as of 12:54 p.m. IST on the NSE. The benchmark NIFTY index is up about 1.27% on the day to 17895.1. The Sensex is at 60096.75, up 1.38%. Gland Pharma Ltd gained around 5.88% in the past month.
Meanwhile, the Nifty Pharma Index, of which Gland Pharma Ltd is a part, has gained around 9.17% over the past month and is currently trading at 13579.9, up 0.87% on the day. The stock’s volume stood at 61,494 shares today, compared to a daily average of 2.03 lakh shares over the past month.
The stock’s PE is 46.12 based on TTM earnings ending Dec. 21.
Powered by Capital Market – Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues. However, we have a request.
As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.
Support quality journalism and subscribe to Business Standard.